Concepedia

Christina Riordan

CR

2

Publications

42

Citations

2

H-Index

2018

Active since

Affiliations

Agenus (United States)(Current)

Genesys (United States)

Incyte (United States)

Christina Riordan is an author at Agenus (United States) specializing in tumor immunity, t cell immunity, and cancer research.

Top concepts

Publications per year

2018–2018

2

Publications

2

Abstract 3819: INCAGN02385 is an antagonist antibody targeting the co-inhibitory receptor LAG-3 for the treatment of human malignancies

David A. Savitsky, Rebecca Ward, Christina Riordan et al. · Cancer Research · 2018 · 24 citations

, , +24

Abstract 3825: INCAGN02390, a novel antagonist antibody that targets the co-inhibitory receptor TIM-3

Jeremy D. Waight, Priyadarshini Iyer, Ekaterina Breous-Nystrom et al. · Cancer Research · 2018 · 18 citations

, , +27

Rows per page

1–2 of 2